Epidemiological projections of viral‐induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination - Institut Pasteur Access content directly
Journal Articles Liver International Year : 2021

Epidemiological projections of viral‐induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination

Abstract

Hepatitis B is an eminent risk factor for hepatocellular carcinoma (HCC) in Southeast Asia and sub-Saharan Africa, whereas hepatitis C is a key risk factor for HCC in Western Europe and North America. Increased awareness of the global burden of viral hepatitis resulted, in May 2016, in the adoption of the first global health sector strategy on viral hepatitis by the World Health Assembly, which calls for the elimina-tion of viral hepatitis as a public health threat by 2030. Although the incidence of liver cancer resulting from viral infections has increased since the 1990s, the imple-mentation of public health interventions, such as hepatitis B vaccination and antiviral therapies might have reduced the global burdens of HCC. Hepatitis B immunization in infancy has been associated with a reduction in the risk of infant fulminant hepati-tis, chronic liver disease, and HCC in Taiwan. Achieving viral hepatitis elimination by 2030 can be accelerated by improving the access to HCC screening programs. HCC surveillance programs in developed countries must be refined to increase an access to personalized surveillance program, whereas the limited access to surveillance and treatment of HCC in developing countries remains a significant public health issue

Dates and versions

pasteur-03697810 , version 1 (17-06-2022)

Identifiers

Cite

Erwan Vo Quang, Yusuke Shimakawa, Pierre Nahon. Epidemiological projections of viral‐induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination. Liver International, 2021, 41 (5), pp.915-927. ⟨10.1111/liv.14843⟩. ⟨pasteur-03697810⟩
30 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More